Delivery Order SPE2DB22D1202-SPE2DB25FVHR3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,503.56 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen (2-pack) pharmaceutical supplies. This firm fixed-price delivery order, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under a larger indefinite...
- The Defense Logistics Agency awarded a $2,106.45 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zymfentra 120 mg/ml pen (2-pack units). This is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.56 to AmerisourceBergen Drug Corp for the supply of Zymfentra 120 mg/ml pen (2-pack units) on August 5, 2025, with an ultimate completion date of August 26, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $3,007.12 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Zymfentra 120 mg/ml pen (2-pack units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 21, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,007.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen (2-pack) pharmaceutical supplies, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of September 2, 2025. This non-competitive delivery order was issued on August 11, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,007.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen kits, with an ultimate completion date of August 25, 2025. This non-set-aside competitive award was issued on August 4, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. As a child order under a larger contract vehicle, this delivery order represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.56 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen kits on August 5, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- This delivery order, valued at $3,007.12 and awarded July 21, 2025, by the Defense Logistics Agency, provides Zymfentra 120 mg/ml pens (2-pack quantity) to support federal medical supply needs. The contract is a firm fixed price delivery order with no set-aside designation, awarded competitively to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. Performance will be completed by August 11, 2025, at the contractor's facility in...
- This delivery order, awarded on July 31, 2025, to AmerisourceBergen Drug Corp under contract number 4568952013, procures Zymfentra 120 mg/ml pen (2-pack) units with a ceiling value of $1,503.56. The contract represents a competitive, non-set-aside award issued under firm fixed price terms, with an ultimate completion date of August 21, 2025. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and fulfillment point for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,503.56 on July 24, 2025, for Zymfentra 120 mg/ml pens (2-packs), with an ultimate completion date of August 14, 2025. This non-set-aside contract utilizes firm fixed pricing and represents performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVHR3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zymfentra 120 mg/ml Pen (2-pack) with a ceiling value of $1,503.56. This competitive, firm fixed-price delivery order is scheduled for completion by September 9, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a pediatric diabetes medication delivery supporting federal medical procurement requirements. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle valued through December 2026 that serves as a comprehensive global pharmaceutical support platform. The parent IDC enables the contractor to supply an extensive range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical supply chains, regularly competing for and receiving competitively awarded contracts across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/18/25 |